rebound weight gain after semaglutide Stopping Semaglutide: How to Prevent Stopping Semaglutide: How to Prevent

In clinical trials, people using GLP-1 drugs lost an average of about 10 pounds more than people using a placebo

Discuss GLP-1 and GIP treatment options, including Tirzepatide, Semaglutide, Mounjaro, Zepbound, Wegovy, and Ozempic for eligible patients

Sandoz CEO Richard Saynor describes Canada as the world's second-largest GLP-1 market, raising cross-border supply concerns as generics near approval.

Semaglutide (commonly referred to as Ozempic) is one well-known name brand of Semaglutide drug

Implementation of GLP-1 RA-specific medical nutrition therapy protocols, with dietitian involvement to optimize dietary recommendations and manage adverse events, is recommended

Employee demand data shows why pharmacy benefits teams are responding